Anamorelin

Also known as: ONO-7643, Adlumiz

Oral ghrelin receptor agonist; stimulates appetite, GH release, and lean mass retention. Non-peptide ghrelin mimetic.

Typical dose

50 mg – 100 mg

Frequency

once daily

Route

Oral

Half-life

7 hours

Routes

Oral

Status

Approved in Japan for cancer cachexia; not FDA-approved in US

Benefits

• Appetite stimulation
• Lean body mass increase
• GH elevation
• Anti-cachexia

Dosing

A common research range for Anamorelin is 50 mg to 100 mg once daily. Oral; 100mg daily on empty stomach. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.

Half-life

Anamorelin has an approximate half-life of 7 hours. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.

Storage

Room temperature.

Reported side effects

• Hyperglycemia
• Nausea
• Increased appetite

Contraindications

• Uncontrolled diabetes
• GI obstruction

Track Anamorelin with Vial

Vial logs every Anamorelin dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →

This page is for educational and harm-reduction purposes only. Anamorelin is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.